Regulus Therapeutics Inc.
Oligomeric compounds and compositions for use in modulation of small non-coding RNAs

Last updated:

Abstract:

Compounds, compositions and methods are provided for modulating the expression and function of small non-coding RNAs. The compositions comprise oligomeric compounds, targeted to small non-coding RNAs. Methods of using these compounds for modulation of small non-coding RNAs as well as downstream targets of these RNAs and for diagnosis and treatment of disease associated with small non-coding RNAs are also provided.

Status:
Grant
Type:

Utility

Filling date:

6 Sep 2018

Issue date:

10 Mar 2020